In this MASCC 2025 series interview, Stephen Casselli, Executive Director of the International Cardio-Oncology Society, discusses the society’s mission to advance cardio-oncology through education, training, and professional development for all healthcare providers involved in cancer care.
He emphasizes the growing need to address cardiotoxic side effects of cancer treatments—an issue impacting countless patients. Together, they’re working to translate the ESC/IC-OS cardio-oncology guidelines into practical tools for cancer physicians.
This conversation underscores the importance of multidisciplinary partnerships to improve survivorship and long-term outcomes for patients.
This video is part of OncoDaily’s special coverage of the MASCC 2025 Annual Meeting.